Costa Rica MedTech Header
Gowned technicians assembling and inspecting medical devices in a clean, modern Costa Rica manufacturing lab.

Laura López: The Economist Behind Costa Rica’s MedTech Boom

Editorial portrait-style illustration of Laura Lopez with abstract blueprint motifs representing trade, data, and the medtech ecosystem.

Laura López:

The Economist Behind Costa Rica’s MedTech Boom

You may know that Costa Rica has become a MedTech powerhouse but do you know that behind all these engineers and managers there is an economist thought leader helping shape the conditions for this economic miracle in the Americas?

Laura López, CEO of PROCOMER (Costa Rica’s Foreign Trade Promotion Agency), represents a less-visible but decisive force behind the country’s rise in high-value, regulated exports: the policy and investment architecture that makes advanced manufacturing viable at scale.

Why this matters to Costa Rica’s MedTech ecosystem

Costa Rica’s medical device cluster is built on technical excellence, design controls, validation discipline, supplier quality, traceability, and a culture of continuous improvement. But regulated, safety-critical industries also depend on something upstream:

  • Predictable investment attraction and expansion pathways (the “how do we keep landing the next plant, line, or capability?” question)
  • Workforce development and capability building aligned with industry needs
  • Export competitiveness in logistics, compliance, and market access
  • Institutional execution that treats data as a first-class asset

PROCOMER sits at the center of those conditions. In La República’s profile, López is presented as the leader driving a results-oriented, data-driven transformation inside the institution, with an emphasis on transparency, ethics, and analytical rigor.

An economist leading with data, clarity, and accountability

López’s leadership philosophy is particularly resonant for organizations operating under strict requirements (like MedTech, aerospace, and other safety-critical sectors) because it mirrors how high-assurance work gets done:

  • Rigor with data is non-negotiable. In regulated environments, “the data are what they are” is not just a motto, it’s a compliance and patient-safety necessity.
  • Clarity in communication reduces risk. Ambiguity creates defects, and defects create rework, or even worse, field issues.
  • Accountability enables speed. When teams can surface errors early without fear, systems improve faster.

In other words, the institutional culture López describes is compatible with the logic of regulated execution: measure what matters, design for learning, and make decisions that can be explained.

Five key ideas of how Laura López is making Procomer and Costa Rica excel

1) Data is governance; not an afterthought

Her insistence on rigorous data is about decision legitimacy. In her framing, you cannot negotiate with evidence: you either confront reality or you drift into “narrative management.

“Rigurosidad con la data es innegociable: uno no disimula ni es flexible con los datos; los datos son lo que son.”

Laura López Salazar, CEO, Procomer, 2026

2) Strategy = fixed destination, flexible route

López distinguishes between being inflexible on purpose and being adaptable on execution. This is a sophisticated way to protect the strategic objective while avoiding the brittle “plan compliance” mindset that fails under uncertainty. For ecosystems like MedTech where constraints and surprises are normal this is a practical definition of resilience.

“El objetivo final permanece claro… lo que más ha cambiado es que ahora lidero con más flexibilidad… no me refiero al objetivo final, sino a ser flexible en cómo llegamos.”

Laura López Salazar, CEO, Procomer, 2026

3) Institutional culture is a scalable competitive advantage

Rather than positioning PROCOMER as a passive agency, she describes it as an engine that can compound national capability over time: ambitious targets, constant measurement, candid course-correction, and an “innovation muscle” that increases with use. This treats public-sector execution as an operating system that can be upgraded, an idea that many export and investment strategies implicitly assume but rarely articulate.

“Va a quedar una organización que no le tiene miedo a la ambición… que no le tiene miedo a decir ‘esto no funcionó, cambiemos el rumbo’.”
“El legado sería una organización que tiene inercia hacia la innovación, no hacia la repetición.”

Laura López Salazar, CEO, Procomer, 2026

4) Talent architecture beats hero leadership

Her definition of leadership is fundamentally combinatorial: the leader’s job is to assemble complementary strengths and keep those strengths aligned to a shared objective. This is a systems view of leadership (not charisma) and it scales, particularly in complex environments where no single person can “know the whole system.”

“El liderazgo es… encontrar lo mejor de cada persona… para lograr la mejor combinación posible y enfrentar los retos.”

Laura López Salazar – CEO, Procomer, 2026

5) Psychological safety with accountability is a design choice

Two of her managerial rules are deceptively advanced: errors must be communicated with urgency, and leaders “own” the failures so the team can take responsible risks. That pairing is how learning organizations move fast without becoming reckless.

“Las cosas buenas y los errores son igualmente importantes de comunicar.”
“Los aplausos son más del equipo, pero las ‘tortas’ son de la jefatura.”

Laura López Salazar – CEO, Procomer, 2026

This is the face of true Costa Rican leadership in 2026, strategic, transparent, data-driven, in one word: SUCCESSFUL

From exporting goods to exporting trust

Costa Rica’s MedTech success has evolved over the decades from a story of cost, geography, and incentives to increasingly becoming a story of trust.

Safety-critical manufacturing exports more than physical products; it exports:

  • validated processes
  • documented evidence
  • auditable supply chains
  • reliable people systems

That is why country-level institutions and leadership matter. A strong MedTech cluster requires a strong “operating system” around it, one that can continuously attract investment, upgrade talent pipelines, and create the conditions for high-value exports to grow.

Takeaways for MedTech leaders and builders

From the lens of costaricamedtech.com, this profile is a useful reminder that ecosystem performance is a multi-layer system:

  1. Engineering excellence scales faster when institutions scale learning.
  2. Data discipline is a competitiveness strategy, not a reporting exercise.
  3. Transparency and ethics are infrastructure for long-term investment.
  4. Diversification into high-value sectors (including MedTech) requires leadership that can balance today’s execution with a ten-year horizon.

Attribution note: This article is an English adaptation and sector-oriented commentary based on the La República profile cited below; it is intended to point readers to the original Spanish publication.

This is adapted for the MedTech community from a Spanish profile published by Periódico La República (Costa Rica). Original source: “Laura López: La Arquitecta de la Transformación Económica de Costa Rica” (May 27, 2026).

La República is highlighting 75 key figures in Costa Rica for their 75th anniversary.

Leave a Reply

Managing Change in Regulated MedTech Software

🧭 TL;DR Who this article is for This article is for MedTech project managers, product managers, software leads, QA/RA, systems engineers, cybersecurity leads, and supplier-quality partners working with regulated software, SaMD and SiMD, connected devices, or hybrid medical-device programs. It is especially useful for teams trying to reconcile two pressures that often feel opposed: How…

Stakeholder Management in MedTech

Stakeholder management in MedTech is not a “soft skill.” It is part of the design-control and risk-control system that determines whether a product can be safely released, adopted, supported, and defended with objective evidence. This article is MedTech-first and experience-based. In regulated medical software, stakeholder management is not just communication. It is how expectations become…

Unpacking the Project Performance Domains

Project performance domains are one of those concepts that sit quietly underneath everything in modern project management: they’re not a “method,” but they often determine whether the work is coherent, repeatable, and value-realizing. I’m writing this from the perspective of a program manager in high‑stakes engineering (MedTech and other regulated environments). I started learning with…

From Sand to Silicon: Semiconductor Materials, Purification, Wafers, Films, and Dopants

Semiconductors are one of those fields where materials science and electronics meet in the most practical way: what a material is (and how clean, ordered, and intentionally “imperfect” it can be made) ultimately determines what circuits can do. I’m writing this series as an electronics engineer, and because earlier in my career I had the…

Agile in regulated medical device software: what TIR45:2023 really added

I believe in starting an Agile roadmap from an agnostic Agile perspective. I focus on the outcomes. I focus on flow. I focus on learning. I do this in any industry. I do it even more in safety-critical industries. That is why I paid close attention to the updates in AAMI TIR45:2023. This update matters.…

CPMAI for MedTech: Design Controls for Data and Models

CPMAI for MedTech: Design Controls for Data and Models AI initiatives often fail for reasons that look familiar to any program leader: unclear goals, mis-scoped solutions, hidden dependencies, and weak validation in real-world conditions. CPMAI (Cognitive Project Management for AI) brings discipline to AI delivery by emphasizing two realities: In MedTech and safety‑critical industries, those…

Something went wrong. Please refresh the page and/or try again.

Discover more from Costa Rica MedTech

Subscribe now to keep reading and get access to the full archive.

Continue reading